Motif Bio Plc (NASDAQ:MTFB) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.

Brokers have set a 12-month consensus price target of $31.50 for the company, according to Zacks. Zacks has also given Motif Bio Plc an industry rank of 167 out of 265 based on the ratings given to its competitors.

Separately, HC Wainwright set a $32.00 price target on Motif Bio Plc and gave the stock a “buy” rating in a research note on Wednesday, October 11th.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/03/motif-bio-plc-mtfb-given-31-50-average-target-price-by-analysts.html.

Get a free copy of the Zacks research report on Motif Bio Plc (MTFB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Motif Bio Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio Plc and related companies with MarketBeat.com's FREE daily email newsletter.